About forty potential vaccines for the Zika virus are being tested, but none are likely to be available for women of childbearing age before 2020, the World Health Organization said today.
WHO director Margaret Chan said the virus, linked to deformations in babies' heads and brains, remained "firmly entrenched" in large parts of the world.
Although progress toward effective prevention has been made, with some drugs now in clinical trials, "a vaccine judged safe enough for use in women of childbearing age may not be fully licensed before 2020," Chan said.
The outbreak, which emerged in Brazil in 2015, has affected some 70 countries.
While Zika, spread by infected mosquitoes as well as by sexual contact, causes only mild symptoms in most people, pregnant women with the virus risk giving birth to babies with microcephaly, a crippling deformation that leads to abnormally small brains and heads.
In June, the WHO said USD 122 million (113 million euros) was needed to fund an 18-month plan to fight infections of women of childbearing age.
WHO director Margaret Chan said the virus, linked to deformations in babies' heads and brains, remained "firmly entrenched" in large parts of the world.
Although progress toward effective prevention has been made, with some drugs now in clinical trials, "a vaccine judged safe enough for use in women of childbearing age may not be fully licensed before 2020," Chan said.
Also Read
The agency declared in November that Zika was no longer a public health emergency, though Chan said today that the WHO was setting up a new support programme for countries around the world.
The outbreak, which emerged in Brazil in 2015, has affected some 70 countries.
While Zika, spread by infected mosquitoes as well as by sexual contact, causes only mild symptoms in most people, pregnant women with the virus risk giving birth to babies with microcephaly, a crippling deformation that leads to abnormally small brains and heads.
In June, the WHO said USD 122 million (113 million euros) was needed to fund an 18-month plan to fight infections of women of childbearing age.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%